Home/Filings/4/0001477449-23-000039
4//SEC Filing

Jensen Claus Torp 4

Accession 0001477449-23-000039

CIK 0001477449other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 4:12 PM ET

Size

12.2 KB

Accession

0001477449-23-000039

Insider Transaction Report

Form 4
Period: 2023-09-01
Jensen Claus Torp
Chief Innovation Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-01+2,04317,946 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-012,80716,845 total
    Common Stock (2,807 underlying)
  • Sale

    Common Stock

    2023-09-05$22.89/sh2,093$47,91715,853 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-012,04314,307 total
    Common Stock (2,043 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-01+2,80715,903 total
Footnotes (4)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  • [F3]On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F4]On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001857993

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:12 PM ET
Size
12.2 KB